Search

Your search keyword '"I, López Carriches"' showing total 5 results
Start Over Author "I, López Carriches"
5 results on '"I, López Carriches"'

1. [Hepatic granulomas in a patient with acquired hypogammaglobulinemia]

Author

T, Artaza Varasa, M, Alcántara Torres, M L, Legaz Huidobro, J J, Sánchez Ruano, I, López Carriches, J F, García García, and J L, Martínez Potenciano

Subjects
Adult, Granuloma, Liver, Agammaglobulinemia, Biopsy, Liver Diseases, Humans, Female, IgG Deficiency
Abstract

The case of a young female diagnosed with an IgG deficit and hepatic granulomas is presented. After 6 years of follow up the patient remains asymptomatic without treatment and with moderate biochemical cholestasis. The tests performed did not lead to a definitive etiologic diagnosis, therefore, according to a review of the literature, we believe that the granulomatous reactions are related with the hypogammaglobulinemia itself.

Published
1996

2. [Recombinant alfa-2 interferon treatment of a patient with chronic hepatitis B and ulcerative colitis]

Author

M L, Legaz Huidobro, T, Artaza Varasa, M, Alcántara Torres, J J, Sánchez Ruano, I, López Carriches, and J L, Martínez Potenciano

Subjects
Adult, Male, Contraindications, Chronic Disease, Interferon Type I, Humans, Colitis, Ulcerative, Hepatitis B, Recombinant Proteins
Abstract

The case of a patient ulcerative colitis involving an autoimmune base who was treated with recombinant alpha-2 interferon for concomitantly presenting chronic hepatitis B in the replicative phase is reported. With this therapy unreplicative seroconversion of the disease was achieved without modification of the course of the chronic inflammatory intestinal disease (CIID) during treatment or over the posttreatment follow up period. A brief review of the literature was performed concerning the role of autoimmunity in ulcerative colitis, treatment with alpha-interferon in chronic hepatitis B and the exacerbation of autoimmune phenomena which may lead to interferon treatment. According to the evolution of this case and the review of the literature, the authors conclude that the existence of CIID does not contra-indicate the use of recombinant alpha-2 interferon in patients with chronic viral hepatitis, although special control of the disease should be carried out during the treatment period.

Published
1996

3. Odontogenic Sinusitis Caused by an Inflammation of a Dentigerous Cyst and Subsequent Finding of a Fibrous Dysplasia. A Case Report.

Author

López-Carriches C, López-Carriches I, and Bryan RB

Abstract

We report the case of a 38-year old male patient with sinusitis caused by an infected follicular cyst due to an ectopic impacted third molar in the right maxillary sinus. A 10-day antibiotherapy regimen was administered; subsequently, the cyst and the third molar were removed achieving complete recovery. Fibrous dysplasia was diagnosed at follow-up examination (occupation of the maxillary sinus by bone tissue was observed in a radiographic examination) and confirmed by biopsy. In cases of odontogenic sinusitis, thorough examination is crucial, as evidenced by the case reported in this study. A Literature review was performed in order to identify the diagnostic methods currently available and the clinical features, complications and treatment for both, odontogenic maxillary sinusitis and fibrous dysplasia.

Published
2016
Full Text
View/download PDF

4. [Hepatic granulomas in a patient with acquired hypogammaglobulinemia].

Author

Artaza Varasa T, Alcántara Torres M, Legaz Huidobro ML, Sánchez Ruano JJ, López Carriches I, García García JF, and Martínez Potenciano JL

Subjects
Adult, Biopsy, Female, Granuloma pathology, Humans, IgG Deficiency complications, Liver pathology, Liver Diseases pathology, Agammaglobulinemia complications, Granuloma etiology, Liver Diseases etiology
Abstract

The case of a young female diagnosed with an IgG deficit and hepatic granulomas is presented. After 6 years of follow up the patient remains asymptomatic without treatment and with moderate biochemical cholestasis. The tests performed did not lead to a definitive etiologic diagnosis, therefore, according to a review of the literature, we believe that the granulomatous reactions are related with the hypogammaglobulinemia itself.

Published
1996

5. [Recombinant alfa-2 interferon treatment of a patient with chronic hepatitis B and ulcerative colitis].

Author

Legaz Huidobro ML, Artaza Varasa T, Alcántara Torres M, Sánchez Ruano JJ, López Carriches I, and Martínez Potenciano JL

Subjects
Adult, Chronic Disease, Colitis, Ulcerative immunology, Contraindications, Humans, Male, Recombinant Proteins, Colitis, Ulcerative complications, Hepatitis B complications, Hepatitis B therapy, Interferon Type I therapeutic use
Abstract

The case of a patient ulcerative colitis involving an autoimmune base who was treated with recombinant alpha-2 interferon for concomitantly presenting chronic hepatitis B in the replicative phase is reported. With this therapy unreplicative seroconversion of the disease was achieved without modification of the course of the chronic inflammatory intestinal disease (CIID) during treatment or over the posttreatment follow up period. A brief review of the literature was performed concerning the role of autoimmunity in ulcerative colitis, treatment with alpha-interferon in chronic hepatitis B and the exacerbation of autoimmune phenomena which may lead to interferon treatment. According to the evolution of this case and the review of the literature, the authors conclude that the existence of CIID does not contra-indicate the use of recombinant alpha-2 interferon in patients with chronic viral hepatitis, although special control of the disease should be carried out during the treatment period.

Published
1996

Catalog

Books, media, physical & digital resources
See catalog results